Indications for allogeneic stem cell transplantation in patients with AML

被引：0
|
作者：
Passweg, J. [1 ]
机构：
[1] Univ Spital Basel, Hamatol, Basel, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V747
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [41] Subsets of CD34 and engraftment kinetics in allogeneic peripheral stem cell transplantation in AML patients
    Pastore, D.
    Mestice, A.
    Carluccio, F.
    Gaudio, F.
    Perrone, T.
    Giordano, A. M.
    Leo, M.
    Giannoccaro, M.
    Pannunzio, A.
    Mongelli, P.
    Di Maso, S.
    Mazzone, A. M.
    Liso, V
    Specchia, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 105 - 105
  • [42] Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML Patients
    Greiner, Jochen
    Goetz, Marlies
    Bunjes, Donald
    Hofmann, Susanne
    Wais, Verena
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [43] Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML
    Dulery, R.
    Nibourel, O.
    Gauthier, J.
    Elsermans, V.
    Behal, H.
    Coiteux, V.
    Magro, L.
    Renneville, A.
    Marceau, A.
    Boyer, T.
    Quesnel, B.
    Preudhomme, C.
    Duhamel, A.
    Yakoub-Agha, I.
    BONE MARROW TRANSPLANTATION, 2017, 52 (04) : 539 - 543
  • [44] Optimization of fludarabine-pharmacokincetics to reduce the ri in AML patients after allogeneic stem cell transplantation
    Thavayogarajah, T.
    Mueller, D.
    Nair, G.
    Balabanov, S.
    Manz, M. G.
    Schanz, U.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 118 - 118
  • [45] Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantation
    Grimm, Juliane
    Jentzsch, Madlen
    Bill, Marius
    Backhaus, Donata
    Brauer, Dominic
    Kuepper, Johannes
    Schulz, Julia
    Franke, Georg-Nikolaus
    Vucinic, Vladan
    Niederwieser, Dietger
    Platzbecker, Uwe
    Schwind, Sebastian
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (10) : 1287 - 1294
  • [46] Allogeneic stem cell transplantation in patients with therapy-related MDS/AML following treatment with radioiodine
    Schroeder, T.
    Kroeger, N.
    Kuendgen, A.
    Platzbecker, U.
    Zohren, F.
    Haas, R.
    Fenk, R.
    Germing, U.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S370 - S370
  • [47] No impact of HLA-C mismatch in patients with AML undergoing allogeneic haematopoietic stem cell transplantation
    Svenberg, P.
    Remberger, M.
    Ringden, O.
    Ljungman, P.
    Gustafsson, B.
    Hauzenberger, D.
    Mattsson, J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S110 - S110
  • [48] External Validation of the Revised PAM Score for Patients with AML Scheduled for Allogeneic Hematopoietic Stem Cell Transplantation
    Kollinger, Frederike
    Middeke, Jan Moritz
    Hardtmann, Maria
    Klesse, Christian
    Stolzel, Friedrich
    Wermke, Martin
    von Bonin, Malte
    Sockel, Katja
    Link, Cornelia S.
    Rollig, Christoph
    Thiede, Christian
    Platzbecker, Uwe
    Ehninger, Gerhard
    Bornhauser, Martin
    Schetelig, Johannes
    BLOOD, 2016, 128 (22)
  • [49] Monosomal Karyotype Predicts Survival In Patients with High Risk AML Undergoing Allogeneic Stem Cell Transplantation
    Middeke, Jan Moritz
    Beelen, Dietrich
    Stadler, Michael
    Baurmann, Herrad
    Bug, Gesine
    Bellos, Frauke
    Mohr, Brigitte
    Birninger, Nicole
    Buchholz, Stefanie
    Schwerdtfeger, Rainer
    Martin, Hans
    Hegenbart, Ute
    Bornhaeuser, Martin
    Ehninger, Gerhard
    Schetelig, Johannes
    BLOOD, 2010, 116 (21) : 1133 - 1134
  • [50] PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation
    J C Albring
    S Inselmann
    T Sauer
    C Schliemann
    B Altvater
    S Kailayangiri
    C Rössig
    W Hartmann
    J R Knorrenschild
    K Sohlbach
    C Groth
    M Lohoff
    A Neubauer
    W E Berdel
    A Burchert
    M Stelljes
    Bone Marrow Transplantation, 2017, 52 : 317 - 320
12345